![Thomas H. Moll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas H. Moll
No open positions remaining
Profile
Thomas H.
Moll worked as Vice President-Immunology at Cardion GmbH from 1998 to 2003.
From 2003 to 2008, served as Vice President-Research at Telos Pharmaceuticals LLC.
Held the position of Vice President-Research at Adamis Pharmaceuticals Corp.
from 2008 to 2009.
Also held roles as Principal at Sandoz AG and Boehringer Ingelheim Chemicals, Inc., Assistant Professor at the University of Münster, and Vice President-Research at DMK Pharmaceuticals Corp.
Education includes a doctorate from the University of Vienna.
Former positions of Thomas H. Moll
| Companies | Position | End |
|---|---|---|
Adamis Pharmaceuticals Corp. /Old/
 Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals products | Chief Tech/Sci/R&D Officer | 2009-04-21 |
Telos Pharmaceuticals LLC | Chief Tech/Sci/R&D Officer | 2007-12-31 |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Corporate Officer/Principal | 2002-12-31 |
The North American Vascular Biology Organization
 The North American Vascular Biology Organization Miscellaneous Commercial ServicesCommercial Services Operates organization for sharing knowledge related to the scientific field of vascular biology | Corporate Officer/Principal | - |
European Society of Gene & Cell Therapy | Corporate Officer/Principal | - |
Training of Thomas H. Moll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Adamis Pharmaceuticals Corp. /Old/
Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals products | Health Technology |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Health Technology |
University of Vienna
 University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Chemicals, Inc.
 Boehringer Ingelheim Chemicals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical ingredients and drug intermediates | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The North American Vascular Biology Organization
The North American Vascular Biology Organization Miscellaneous Commercial ServicesCommercial Services Operates organization for sharing knowledge related to the scientific field of vascular biology | Commercial Services |
The American Association of Immunologists
 The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a company based in Bethesda, MD. | Commercial Services |
Telos Pharmaceuticals LLC | |
DMK Pharmaceuticals Corp.
 DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders | Health Technology |
The American Society of Transplantation
 The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides transplantation and patient care services | Commercial Services |
European Society of Gene & Cell Therapy |
- Stock Market
- Insiders
- Thomas H. Moll
